Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
NASDAQ:IRTC
IRTC Analyst Ratings
Strong Buy
12 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IRTC Stock 12 Month Forecast
Average Price Target
$220.38
▲(30.53% Upside)
| Highest Price Target$244.00 | Average Price Target$220.38 | Lowest Price Target$185.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citi
$242
Buy
43.34%
Upside
Reiterated
12/11/25
Morgan Stanley
$195→$205
Buy
21.42%
Upside
Reiterated
12/02/25
Bank of America Securities
$225
Buy
33.27%
Upside
Reiterated
11/18/25
Confident Buy Rating for Irhythm Technologies Amidst LCD Concerns and Market Expansion OpportunitiesWe caught up with IRTC after it became a focus for investors yesterday. This isn’t new news given it was in the 10Q and we would expect the language in the proposed LCD to be changed, as we go through below, so we don’t view this as a big risk for IRTC. We maintain our Buy as strong execution in the core business continues, TAM expansion opportunities increasingly contribute to growth, and profitability improves. Proposed LCD implications for LTCM and timing The proposed LCD applies to ambulatory cardiac monitoring broadly but inadvertently applies requirements for MCT to other modalities including LTCM, Holter and event monitoring. The biggest potential implication is 24-hour monitoring for LTCM. The main risk is IRTC’s business model from a cost perspective is not set up for 24-hour LTCM.
BTIG
$215
Buy
27.35%
Upside
Reiterated
11/17/25
Truist Financial
$205→$230
Buy
36.23%
Upside
Reiterated
10/31/25
Oppenheimer
$175→$225
Buy
33.27%
Upside
Reiterated
10/31/25
Robert W. Baird
$220→$235
Buy
39.19%
Upside
Reiterated
10/31/25
Canaccord Genuity
$193→$212
Buy
25.57%
Upside
Reiterated
10/31/25
J.P. Morgan
$190→$240
Buy
42.15%
Upside
Reiterated
10/31/25
Needham
$193→$244
Buy
44.52%
Upside
Reiterated
10/31/25
William Blair
―
Buy
―
Reiterated
10/31/25
Goldman Sachs
$180→$202
Hold
19.65%
Upside
Reiterated
10/31/25
Freedom Capital Markets
$205
Buy
21.42%
Upside
Initiated
10/13/25
Evercore ISI
$185
Hold
9.58%
Upside
Initiated
09/23/25
Wells Fargo
$130→$180
Buy
6.62%
Upside
Reiterated
08/01/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
$242
Buy
43.34%
Upside
Reiterated
12/11/25
Morgan Stanley
$195→$205
Buy
21.42%
Upside
Reiterated
12/02/25
Bank of America Securities
$225
Buy
33.27%
Upside
Reiterated
11/18/25
Confident Buy Rating for Irhythm Technologies Amidst LCD Concerns and Market Expansion OpportunitiesWe caught up with IRTC after it became a focus for investors yesterday. This isn’t new news given it was in the 10Q and we would expect the language in the proposed LCD to be changed, as we go through below, so we don’t view this as a big risk for IRTC. We maintain our Buy as strong execution in the core business continues, TAM expansion opportunities increasingly contribute to growth, and profitability improves. Proposed LCD implications for LTCM and timing The proposed LCD applies to ambulatory cardiac monitoring broadly but inadvertently applies requirements for MCT to other modalities including LTCM, Holter and event monitoring. The biggest potential implication is 24-hour monitoring for LTCM. The main risk is IRTC’s business model from a cost perspective is not set up for 24-hour LTCM.
BTIG
$215
Buy
27.35%
Upside
Reiterated
11/17/25
Truist Financial
$205→$230
Buy
36.23%
Upside
Reiterated
10/31/25
Oppenheimer
$175→$225
Buy
33.27%
Upside
Reiterated
10/31/25
Robert W. Baird
$220→$235
Buy
39.19%
Upside
Reiterated
10/31/25
Canaccord Genuity
$193→$212
Buy
25.57%
Upside
Reiterated
10/31/25
J.P. Morgan
$190→$240
Buy
42.15%
Upside
Reiterated
10/31/25
Needham
$193→$244
Buy
44.52%
Upside
Reiterated
10/31/25
William Blair
―
Buy
―
Reiterated
10/31/25
Goldman Sachs
$180→$202
Hold
19.65%
Upside
Reiterated
10/31/25
Freedom Capital Markets
$205
Buy
21.42%
Upside
Initiated
10/13/25
Evercore ISI
$185
Hold
9.58%
Upside
Initiated
09/23/25
Wells Fargo
$130→$180
Buy
6.62%
Upside
Reiterated
08/01/25
Best Analysts Covering Irhythm Technologies
1 Month
xxx
Success Rate
13/20 ratings generated profit
Average Return
+1.47%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.00% of your transactions generating a profit, with an average return of +1.47% per trade.
3 Months
xxx
Success Rate
12/19 ratings generated profit
Average Return
+8.02%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.16% of your transactions generating a profit, with an average return of +8.02% per trade.
1 Year
Success Rate
11/19 ratings generated profit
Average Return
+36.66%
reiterated a buy rating last month
Copying Richard Newitter's trades and holding each position for 1 Year would result in 57.89% of your transactions generating a profit, with an average return of +36.66% per trade.
2 Years
xxx
Success Rate
18/19 ratings generated profit
Average Return
+69.64%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 94.74% of your transactions generating a profit, with an average return of +69.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IRTC Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
23
21
33
21
20
Hold
5
5
6
5
5
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
28
26
39
27
26
Each month's total comprises the sum of three months' worth of ratings.
IRTC Financial Forecast
IRTC Stock Forecast FAQ
What is IRTC’s average 12-month price target, according to analysts?
Based on analyst ratings, Irhythm Technologies’s 12-month average price target is 220.38.
What is IRTC’s upside potential, based on the analysts’ average price target?
Irhythm Technologies has 30.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IRTC a Buy, Sell or Hold?
Irhythm Technologies has a consensus rating of Strong Buy which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
What is Irhythm Technologies’s price target?
The average price target for Irhythm Technologies is 220.38. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $244.00 ,the lowest forecast is $185.00. The average price target represents 30.53% Increase from the current price of $168.83.
The highest analyst price target is $244.00 ,the lowest forecast is $185.00. The average price target represents 30.53% Increase from the current price of $168.83.
What do analysts say about Irhythm Technologies?
Irhythm Technologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of IRTC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.